The reboot approach significantly reduced nasal polyp recurrence for 30 months postoperatively compared to the current mucosa-sparing approach.
Practice Focus » Rhinology
Multiple therapeutic options may be effective for treating mild pediatric OSA including observation, management with anti-inflammatory medications, and surgery.
HTA and the Systematic Human Error Reduction and Prediction Approach (SHERPA) are valuable tools to highlight potential errors in functional endoscopic sinus surgery (FESS).
Olfaction can be improved by sinus surgery in about every second chronic rhinosinusitis (CRS) patient.
A look at how effective systemic tranexamic acid is compared to a control in blood loss, operative time, and surgical field and incidence of postoperative emesis and thromboembolism in endoscopic sinus surgery (ESS).
Tissue eosinophil aggregates appear to be the largest driving factor for increased prednisone requirements after sinus surgery to control mucosal disease than the mere presence of eosinophils.